President Trump Proposes Tariffs on Generic Pharmaceuticals to Reshore Production
President Trump has announced a proposal to impose 100% tariffs on generic pharmaceuticals starting in 2028, with plans to increase the tariffs to 200% thereafter. The initiative aims to encourage the reshoring of generic drug production to the United States. This move is part of a broader strategy to reduce dependency on foreign pharmaceutical imports, particularly from countries like India, which currently supplies nearly half of the generic medicines consumed in the U.S. The proposal is expected to have significant implications for the pharmaceutical industry, potentially affecting drug prices and availability. 
